Sitamaquine as a putative antileishmanial drug candidate: from the mechanism of action to the risk of drug resistance
Parasite, 18 2 (2011) 115-119
Published online: 2011-05-15
Articles citing this article
The Citing articles tool gives a list of articles citing the current article.
The citing articles come from EDP Sciences database, as well as other publishers participating in CrossRef Cited-by Linking Program. You can set up your personal account to receive an email alert each time this article is cited by a new article (see the menu on the right-hand side of the abstract page).
Cited article:
This article has been cited by the following article(s):
Genomic Insight of Leishmania Parasite: In-Depth Review of Drug Resistance Mechanisms and Genetic Mutations
Krupanshi Bharadava, Tarun Kumar Upadhyay, Radhey Shyam Kaushal, Irfan Ahmad, Yasser Alraey, Samra Siddiqui and Mohd SaeedACS Omega (2024)
https://doi.org/10.1021/acsomega.3c09400
207 23 (2024)
https://doi.org/10.1016/bs.pmbts.2024.05.001
Evaluation of the inhibitory effects of sitamaquine on Babesia infections
Dongxue Ma, Karuna Sekiguchi, Eloiza May Galon, Mingming Liu, Shengwei Ji and Xuenan XuanParasitology International 103 102941 (2024)
https://doi.org/10.1016/j.parint.2024.102941
Evolution of the Quinoline Scaffold for the Treatment of Leishmaniasis: A Structural Perspective
Carlos F. M. Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. SilvaPharmaceuticals 17 (3) 285 (2024)
https://doi.org/10.3390/ph17030285
Exploration of Synthetic Potential of Quinoline‐3‐Carbaldehydes
Vipin Kumar, Shubham Sharma, Vaishali, Dharmender Singh, Chandi C. Malakar and Virender SinghEuropean Journal of Organic Chemistry (2024)
https://doi.org/10.1002/ejoc.202400456
Pathobiology of Parasitic Protozoa: Dynamics and Dimensions
Satya Prakash and Ambak Kumar RaiPathobiology of Parasitic Protozoa: Dynamics and Dimensions 19 (2023)
https://doi.org/10.1007/978-981-19-8225-5_2
479 (2023)
https://doi.org/10.1007/978-981-99-2302-1_20
A review on new natural and synthetic anti-leishmanial chemotherapeutic agents and current perspective of treatment approaches.
Nilanjana Majumder, Antara Banerjee and Samiran SahaActa Tropica 240 106846 (2023)
https://doi.org/10.1016/j.actatropica.2023.106846
Diarylpentanoids, the privileged scaffolds in antimalarial and anti‐infectives drug discovery: A review
Amirah H. Ramli and Siti M. Mohd FaudziArchiv der Pharmazie 356 (12) (2023)
https://doi.org/10.1002/ardp.202300391
Quinolinyl β-enaminone derivatives exhibit leishmanicidal activity against Leishmania donovani by impairing the mitochondrial electron transport chain complex and inducing ROS-mediated programmed cell death
Ankita Rani, Shilpika Khanikar, Mukul Dutta, et al.Journal of Antimicrobial Chemotherapy 78 (2) 359 (2023)
https://doi.org/10.1093/jac/dkac395
Immunotherapy and immunochemotherapy in combating visceral leishmaniasis
Ganesh Yadagiri, Aakriti Singh, Kanika Arora and Shyam Lal MudavathFrontiers in Medicine 10 (2023)
https://doi.org/10.3389/fmed.2023.1096458
531 (2023)
https://doi.org/10.1007/978-3-031-15130-9_49
Discovery of 2,3-dihydro-1H-pyrrolo[3,4-b]quinolin-1-one derivatives as possible antileishmanial agents
Anuradha Seth, Anirban Ghoshal, Varun Dewaker, et al.RSC Medicinal Chemistry 13 (6) 746 (2022)
https://doi.org/10.1039/D2MD00078D
Evolution of Acridines and Xanthenes as a Core Structure for the Development of Antileishmanial Agents
Carlos F. M. Silva, Diana C. G. A. Pinto, Pedro A. Fernandes and Artur M. S. SilvaPharmaceuticals 15 (2) 148 (2022)
https://doi.org/10.3390/ph15020148
Antiprotozoal agents: How have they changed over a decade?
Vitória de Souza Fernandes, Rafael da Rosa, Lara A. Zimmermann, Kamilla R. Rogério, Arthur E. Kümmerle, Lilian S. C. Bernardes and Cedric S. GraebinArchiv der Pharmazie 355 (2) (2022)
https://doi.org/10.1002/ardp.202100338
Current leishmaniasis drug discovery
Alessandra Campbell Pinheiro and Marcus Vinícius Nora de SouzaRSC Medicinal Chemistry 13 (9) 1029 (2022)
https://doi.org/10.1039/D1MD00362C
The Potential of 2-Substituted Quinolines as Antileishmanial Drug Candidates
Philippe M. Loiseau, Kaluvu Balaraman, Gillian Barratt, Sébastien Pomel, Rémy Durand, Frédéric Frézard and Bruno FigadèreMolecules 27 (7) 2313 (2022)
https://doi.org/10.3390/molecules27072313
In vitro evaluation and in vivo efficacy of nitroimidazole-sulfanyl ethyl derivatives against Leishmania (V.) braziliensis and Leishmania (L.) mexicana
Zuleima Blanco, Michael R. Mijares, Hegira Ramírez, et al.Parasitology Research 120 (9) 3307 (2021)
https://doi.org/10.1007/s00436-021-07266-w
Overcoming multi‐resistant leishmania treatment by nanoencapsulation of potent antimicrobials
Simone SC Oliveira, Carine S Ferreira, Marta H Branquinha, André LS Santos, Marco V Chaud, Sona Jain, Juliana C Cardoso, Anđelka B Kovačević, Eliana B Souto and Patrícia SeverinoJournal of Chemical Technology & Biotechnology 96 (8) 2123 (2021)
https://doi.org/10.1002/jctb.6633
Palladium-mediated synthesis and biological evaluation of C-10b substituted Dihydropyrrolo[1,2-b]isoquinolines as antileishmanial agents
Iratxe Barbolla, Leidi Hernández-Suárez, Viviana Quevedo-Tumailli, et al.European Journal of Medicinal Chemistry 220 113458 (2021)
https://doi.org/10.1016/j.ejmech.2021.113458
Progress in the Chemistry of Organic Natural Products 115
Jiří Pospíšil, Daniela Konrádová and Miroslav StrnadProgress in the Chemistry of Organic Natural Products, Progress in the Chemistry of Organic Natural Products 115 115 115 (2021)
https://doi.org/10.1007/978-3-030-64853-4_3
Quinoline-based Compounds as Key Candidates to Tackle Drug Discovery Programs of Microbicidal Agents
Aline N. Silva da Gama and Maria N.C. SoeiroCurrent Pharmaceutical Design 27 (15) 1757 (2021)
https://doi.org/10.2174/1381612826666201006125644
Biological Evaluation and Mechanistic Studies of Quinolin-(1 H )-Imines as a New Chemotype against Leishmaniasis
Ana Georgina Gomes-Alves, Margarida Duarte, Tânia Cruz, et al.Antimicrobial Agents and Chemotherapy 65 (7) (2021)
https://doi.org/10.1128/AAC.01513-20
Lymphatic filariasis and visceral leishmaniasis coinfection: A review on their epidemiology, therapeutic, and immune responses
Vikas Kushwaha and Sukhbir KaurActa Tropica 224 106117 (2021)
https://doi.org/10.1016/j.actatropica.2021.106117
Pre-clinical evidences of the antileishmanial effects of diselenides and selenocyanates
Pablo Garnica, Mikel Etxebeste-Mitxeltorena, Daniel Plano, et al.Bioorganic & Medicinal Chemistry Letters 30 (17) 127371 (2020)
https://doi.org/10.1016/j.bmcl.2020.127371
Synthesis and leishmanicidal evaluation of sulfanyl‐ and sulfonyl‐tethered functionalized benzoate derivatives featuring a nitroimidazole moiety
Miguel Rodríguez, Joyce Gutiérrez, José Domínguez, Philippe A. Peixoto, Alexis Fernández, Noris Rodríguez, Denis Deffieux, Luis Rojas, Stéphane Quideau, Laurent Pouységu and Jaime CharrisArchiv der Pharmazie 353 (5) (2020)
https://doi.org/10.1002/ardp.202000002
Review on natural products as an alternative to contemporary anti-leishmanial therapeutics
Shweta Raj, Santanu Sasidharan, S. N. Balaji, Vikash Kumar Dubey and Prakash SaudagarJournal of Proteins and Proteomics 11 (2) 135 (2020)
https://doi.org/10.1007/s42485-020-00035-w
Searching for drugs for Chagas disease, leishmaniasis and schistosomiasis: a review
Soraya Silva Santos, Renan Vinicius de Araújo, Jeanine Giarolla, Omar El Seoud and Elizabeth Igne FerreiraInternational Journal of Antimicrobial Agents 55 (4) 105906 (2020)
https://doi.org/10.1016/j.ijantimicag.2020.105906
Nanotechnology in Skin, Soft Tissue, and Bone Infections
Marco Vinicius Chaud, Venâncio Alves Amaral, Fernando Batain, et al.Nanotechnology in Skin, Soft Tissue, and Bone Infections 183 (2020)
https://doi.org/10.1007/978-3-030-35147-2_11
Synthesis, Characterization, and Antileishmanial Activity of Certain Quinoline-4-carboxylic Acids
Mazin A. S. Abdelwahid, Tilal Elsaman, Malik S. Mohamed, et al.Journal of Chemistry 2019 1 (2019)
https://doi.org/10.1155/2019/2859637
Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
Eliana B. Souto, João Dias-Ferreira, Sara A. Craveiro, Patrícia Severino, Elena Sanchez-Lopez, Maria L. Garcia, Amélia M. Silva, Selma B. Souto and Sheefali MahantPathogens 8 (3) 119 (2019)
https://doi.org/10.3390/pathogens8030119
Enhancing the copy number of Ldrab6 gene in Leishmania donovani parasites mediates drug resistance through drug‐thiol conjugate dependent multidrug resistance protein A (MRPA)
Indira Singh Chauhan, G. Subba Rao and Neeloo SinghActa Tropica 199 105158 (2019)
https://doi.org/10.1016/j.actatropica.2019.105158
Structure-activity relationships and mechanistic studies of novel mitochondria-targeted, leishmanicidal derivatives of the 4-aminostyrylquinoline scaffold
Matteo Staderini, Marta Piquero, María Ángeles Abengózar, et al.European Journal of Medicinal Chemistry 171 38 (2019)
https://doi.org/10.1016/j.ejmech.2019.03.007
Exploiting knowledge on pharmacodynamics-pharmacokinetics for accelerated anti-leishmanial drug discovery/development
Shyam Sundar, Neha Agrawal and Bhawana SinghExpert Opinion on Drug Metabolism & Toxicology 15 (7) 595 (2019)
https://doi.org/10.1080/17425255.2019.1629417
Discovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases
Vladimir V. Kouznetsov, Carlos M. Meléndez Gómez, José Luis Valencia Peña and Leonor Y. Vargas-MéndezDiscovery and Development of Therapeutics from Natural Products Against Neglected Tropical Diseases 87 (2019)
https://doi.org/10.1016/B978-0-12-815723-7.00004-3
Synthesis and biological evaluation of new quinoline derivatives as antileishmanial and antitrypanosomal agents
Santiago N. Chanquia, Facundo Larregui, Vanesa Puente, et al.Bioorganic Chemistry 83 526 (2019)
https://doi.org/10.1016/j.bioorg.2018.10.053
The alkylaminoalkanethiosulfuric acids exhibit in-vitro antileishmanial activity against Leishmania (Viannia) braziliensis: a new perspective for use of these schistosomicidal agents
Gabriane Nascimento Porcino, Luciana Maria Ribeiro Antinarelli, Ana Carolina Ribeiro Gomes Maia, et al.Journal of Pharmacy and Pharmacology 71 (12) 1784 (2019)
https://doi.org/10.1111/jphp.13163
Synthesis, Biological Evaluation, Structure–Activity Relationship, and Mechanism of Action Studies of Quinoline–Metronidazole Derivatives Against Experimental Visceral Leishmaniasis
Akanksha Upadhyay, Pragya Chandrakar, Sampa Gupta, et al.Journal of Medicinal Chemistry 62 (11) 5655 (2019)
https://doi.org/10.1021/acs.jmedchem.9b00628
Targeting Pteridine Reductase 1 and Dihydrofolate Reductase: The Old is a New Trend for Leishmaniasis Drug Discovery
Gustavo Machado das Neves, Luciano P Kagami, Itamar L Gonçalves and Vera L Eifler-LimaFuture Medicinal Chemistry 11 (16) 2107 (2019)
https://doi.org/10.4155/fmc-2018-0512
Cinnamic Acid Conjugates in the Rescuing and Repurposing of Classical Antimalarial Drugs
Ana Teresa Silva, Clara M. Bento, Ana C. Pena, Luísa M. Figueiredo, Cristina Prudêncio, Luísa Aguiar, Tânia Silva, Ricardo Ferraz, Maria Salomé Gomes, Cátia Teixeira and Paula GomesMolecules 25 (1) 66 (2019)
https://doi.org/10.3390/molecules25010066
Neglected Diseases: Extensive Space for Modern Drug Discovery
Chiara Borsari, Antonio Quotadamo, Stefania Ferrari, et al.Annual Reports in Medicinal Chemistry, Neglected Diseases: Extensive Space for Modern Drug Discovery 51 39 (2018)
https://doi.org/10.1016/bs.armc.2018.08.002
Antileishmanial activity of a 4-hydrazinoquinoline derivative: Induction of autophagy and apoptosis-related processes and effectiveness in experimental cutaneous leishmaniasis
Luciana Maria Ribeiro Antinarelli, Isabela de Oliveira Souza, Priscila Vanessa Zabala Capriles, et al.Experimental Parasitology 195 78 (2018)
https://doi.org/10.1016/j.exppara.2018.10.007
Drug Resistance in Leishmania Parasites
Emilia Díaz and Alicia Ponte-SucreDrug Resistance in Leishmania Parasites 1 (2018)
https://doi.org/10.1007/978-3-319-74186-4_1
Infectious Diseases and Your Health
Ganesh Yadagiri and Prati Pal SinghInfectious Diseases and Your Health 63 (2018)
https://doi.org/10.1007/978-981-13-1577-0_5
Novel Aminoquinoline Derivatives Significantly Reduce Parasite Load in Leishmania infantum Infected Mice
Jelena Konstantinović, Milica Videnović, Stefania Orsini, et al.ACS Medicinal Chemistry Letters 9 (7) 629 (2018)
https://doi.org/10.1021/acsmedchemlett.8b00053
Antimicrobial Drug Resistance
Goutam Mandal, Vaidya Govindarajan, Mansi Sharma, Hiranmoy Bhattacharjee and Rita MukhopadhyayAntimicrobial Drug Resistance 649 (2017)
https://doi.org/10.1007/978-3-319-46718-4_42
An overview of azoles targeting sterol 14α-demethylase for antileishmanial therapy
Saeed Emami, Pegah Tavangar and Masoud KeighobadiEuropean Journal of Medicinal Chemistry 135 241 (2017)
https://doi.org/10.1016/j.ejmech.2017.04.044
Anti-trypanosomatid drug discovery: an ongoing challenge and a continuing need
Mark C. Field, David Horn, Alan H. Fairlamb, et al.Nature Reviews Microbiology 15 (4) 217 (2017)
https://doi.org/10.1038/nrmicro.2016.193
Polyamine-based analogs and conjugates as antikinetoplastid agents
Elodie Jagu, Sébastien Pomel, Stéphanie Pethe, Philippe M. Loiseau and Raphaël LabruèreEuropean Journal of Medicinal Chemistry 139 982 (2017)
https://doi.org/10.1016/j.ejmech.2017.08.014
Drug Discovery for Leishmaniasis
Ana Martinez and Carmen GilDrug Discovery for Leishmaniasis 153 (2017)
https://doi.org/10.1039/9781788010177-00153
Handbook of Antimicrobial Resistance
Danielle Légaré and Marc OuelletteHandbook of Antimicrobial Resistance 313 (2017)
https://doi.org/10.1007/978-1-4939-0694-9_17
Library of Seleno-Compounds as Novel Agents against Leishmania Species
Álvaro Martín-Montes, Daniel Plano, Rubén Martín-Escolano, et al.Antimicrobial Agents and Chemotherapy 61 (6) (2017)
https://doi.org/10.1128/AAC.02546-16
In vitro antileishmanial activity of aza-scorpiand macrocycles. Inhibition of the antioxidant enzyme iron superoxide dismutase
Clotilde Marín, Mario Inclán, Inmaculada Ramírez-Macías, et al.RSC Advances 6 (21) 17446 (2016)
https://doi.org/10.1039/C5RA21262F
Aminoquinoline compounds: Effect of 7-chloro-4-quinolinylhydrazone derivatives against Leishmania amazonensis
Luciana Maria Ribeiro Antinarelli, Isabela de Oliveira Souza, Nicolas Glanzmann, et al.Experimental Parasitology 171 10 (2016)
https://doi.org/10.1016/j.exppara.2016.10.009
Novel Heteroaryl Selenocyanates and Diselenides as Potent Antileishmanial Agents
Ylenia Baquedano, Verónica Alcolea, Miguel Ángel Toro, et al.Antimicrobial Agents and Chemotherapy 60 (6) 3802 (2016)
https://doi.org/10.1128/AAC.02529-15
Reference Module in Biomedical Sciences
J. Schrevel and P.M. LoiseauReference Module in Biomedical Sciences (2016)
https://doi.org/10.1016/B978-0-12-801238-3.97819-X
Zinc(II)-Dipicolylamine Coordination Complexes as Targeting and Chemotherapeutic Agents for Leishmania major
Douglas R. Rice, Paola Vacchina, Brianna Norris-Mullins, Miguel A. Morales and Bradley D. SmithAntimicrobial Agents and Chemotherapy 60 (5) 2932 (2016)
https://doi.org/10.1128/AAC.00410-16
Eliminating the Neglected Tropical Diseases: Translational Science and New Technologies
Peter J. Hotez, Bernard Pecoul, Suman Rijal, et al.PLOS Neglected Tropical Diseases 10 (3) e0003895 (2016)
https://doi.org/10.1371/journal.pntd.0003895
The Dialogue of the Host-Parasite Relationship:Leishmaniaspp. andTrypanosoma cruziInfection
Carlos Gustavo Vieira de Morais, Ana Karina Castro Lima, Rodrigo Terra, et al.BioMed Research International 2015 1 (2015)
https://doi.org/10.1155/2015/324915
Investigational drugs for visceral leishmaniasis
Shyam Sundar and Jaya ChakravartyExpert Opinion on Investigational Drugs 24 (1) 43 (2015)
https://doi.org/10.1517/13543784.2014.954035
Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series
Charline Kieffer, Anita Cohen, Pierre Verhaeghe, et al.Bioorganic & Medicinal Chemistry 23 (10) 2377 (2015)
https://doi.org/10.1016/j.bmc.2015.03.064
Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning
Marcel Kaiser, Pascal Mäser, Leela Pavan Tadoori, et al.PLOS ONE 10 (8) e0135556 (2015)
https://doi.org/10.1371/journal.pone.0135556
4‐Aminoquinoline Derivatives as Potential Antileishmanial Agents
Luciana M. R. Antinarelli, Rafael M. P. Dias, Isabela O. Souza, Wallace P. Lima, Jacy Gameiro, Adilson D. da Silva and Elaine S. CoimbraChemical Biology & Drug Design 86 (4) 704 (2015)
https://doi.org/10.1111/cbdd.12540
Imidazole-containing phthalazine derivatives inhibit Fe-SOD performance in Leishmania species and are active in vitro against visceral and mucosal leishmaniasis
M. SÁNCHEZ-MORENO, F. GÓMEZ-CONTRERAS, P. NAVARRO, et al.Parasitology 142 (8) 1115 (2015)
https://doi.org/10.1017/S0031182015000219
Finding of leishmanicidal activity of 14-hydroxylunularin in mice experimentally infected with Leishmania infantum
Ma. Elva Serna, Marisel Maldonado, Susana Torres, et al.Parasitology International 64 (5) 295 (2015)
https://doi.org/10.1016/j.parint.2015.03.005
European Handbook of Dermatological Treatments
Meltem Onder and Mehmet Ali GürerEuropean Handbook of Dermatological Treatments 495 (2015)
https://doi.org/10.1007/978-3-662-45139-7_50
Handbook of Antimicrobial Resistance
Danielle Légaré and Marc OuelletteHandbook of Antimicrobial Resistance 1 (2014)
https://doi.org/10.1007/978-1-4939-0667-3_17-1
Natural product based leads to fight against leishmaniasis
Nisha Singh, Bhuwan B. Mishra, Surabhi Bajpai, Rakesh K. Singh and Vinod K. TiwariBioorganic & Medicinal Chemistry 22 (1) 18 (2014)
https://doi.org/10.1016/j.bmc.2013.11.048
Humanized mouse model of glucose 6-phosphate dehydrogenase deficiency for in vivo assessment of hemolytic toxicity
Rosemary Rochford, Colin Ohrt, Paul C. Baresel, et al.Proceedings of the National Academy of Sciences 110 (43) 17486 (2013)
https://doi.org/10.1073/pnas.1310402110
Developments in diagnosis and treatment of visceral leishmaniasis during the last decade and future prospects
Sarfaraz Ahmad Ejazi and Nahid AliExpert Review of Anti-infective Therapy 11 (1) 79 (2013)
https://doi.org/10.1586/eri.12.148
Drug Resistance in Leishmania Parasites
A. Ponte-SucreDrug Resistance in Leishmania Parasites 1 (2013)
https://doi.org/10.1007/978-3-7091-1125-3_1
Anti-leishmanial evaluation of C2-aryl quinolines: Mechanistic insight on bioenergetics and sterol biosynthetic pathway of Leishmania braziliensis
Daznia Bompart, Jorge Núñez-Durán, Daniel Rodríguez, et al.Bioorganic & Medicinal Chemistry 21 (14) 4426 (2013)
https://doi.org/10.1016/j.bmc.2013.04.063
Topical Treatment Modalities for Old World Cutaneous Leishmaniasis: A Review
R. Alavi-Naini, Asghar Fazaeli and T. O'DempseyPrague Medical Report 113 (2) 105 (2012)
https://doi.org/10.14712/23362936.2015.26
Peptidomimetic and Organometallic Derivatives of Primaquine Active against Leishmania infantum
Sílvia Vale-Costa, Nuno Vale, Joana Matos, et al.Antimicrobial Agents and Chemotherapy 56 (11) 5774 (2012)
https://doi.org/10.1128/AAC.00873-12
Host-Parasite Interaction: Parasite-Derived and -Induced Proteases That Degrade Human Extracellular Matrix
Carolina Piña-Vázquez, Magda Reyes-López, Guillermo Ortíz-Estrada, Mireya de la Garza and Jesús Serrano-LunaJournal of Parasitology Research 2012 1 (2012)
https://doi.org/10.1155/2012/748206